Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 4, 2022
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
[ Tue, Jan 04th 2022
] - WOPRAI
Mon, January 3, 2022
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
[ Mon, Jan 03rd 2022
] - WOPRAI
Edward Tenthoff Upgraded (ALNY) to Buy and Increased Target to $208 on, Jan 3rd, 2022
Edward Tenthoff of Piper Sandler, Upgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Buy and Increased Target from $181 to $208 on, Jan 3rd, 2022.
Edward has made no other calls on ALNY in the last 4 months.
There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $108 on, Thursday, October 28th, 2021
These are the ratings of the 7 analyists that currently disagree with Edward
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $205 on, Monday, November 22nd, 2021
- Luca Issi of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $225 on, Monday, November 22nd, 2021
- Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $273 on, Monday, November 22nd, 2021
- Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $200 on, Monday, November 1st, 2021
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $200 on, Friday, October 29th, 2021
- David Lebowitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $226 on, Friday, October 29th, 2021
- Esther Rajavelu of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $215 on, Monday, October 4th, 2021
